Results 91 to 100 of about 644,370 (183)

Pharmacophoric Investigation of a Natural Product-like Class of Aromatase Inhibitors Using Molecular Modeling. [PDF]

ACS Omega
Held A, Esselman A, Huebner M, Frietas G, Boyson B, Walker M, Miller B.   +6 more
europepmc   +1 more source

Corrigendum to "Computational screening of <i>Sophora flavescens</i> phytochemicals as potential aromatase inhibitors: Molecular docking, ADMET, Network pharmacology, Molecular dynamics simulation, and DFT studies" [Pharmaceutic. Sci. Adv. 4 (2026) 100108]. [PDF]

Pharm Sci Adv
Rashid L, Tasnim J, Mehedi Hasan M, Ismail H, Hossain KR, Sarker S, Younas A, Mujtaba M, Alam MT.   +8 more
europepmc   +1 more source

Cardiovascular Risks of Aromatase Inhibitors versus Tamoxifen in Postmenopausal Breast Cancer: A Multinational Cohort Study. [PDF]

Clin Epidemiol
Hu SC, Gaber CE, Lo C, Su HN, Wang CC, Yeh CF, Hassan L, Pickard AS, Lee TA, Lin FJ.   +9 more
europepmc   +1 more source

Response to "Aromatase Inhibitors and Dementia Risk: Putting Safety Into Perspective". [PDF]

Pharmacol Res Perspect
Yuste MT, Sainz-Gil M, Escudero E, Marín P.   +3 more
europepmc   +1 more source

Exploring the Impact of In Ovo Injection of Flavonoid-Based Aromatase Inhibitors on Gonadal Histology Differentiation in Ross 308 Broiler Chickens. [PDF]

Vet Med Sci
Akbari-Balajorshari A, Mottaghitalab M, Hossein-Zadeh NG, Mohammadghasemi F.   +3 more
europepmc   +1 more source

Adiposity Excess and Vertebral Fractures in Patients With Breast Cancer Taking Aromatase Inhibitors.

JAMA Netw Open
Schivardi G, Cosentini D, Scartabellati G, Ravanelli M, Moretti L, Mazziotti G, Bazzoli M, Strazzeri S, Delbarba A, Grisanti S, Laganà M, Turla A, Chiara ED, Cappelli C, Farina D, Calza S, Donato F, Berruti A, Pedersini R.   +18 more
europepmc   +1 more source

Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New <i>N</i>-Heterocyclic Compounds as Aromatase Inhibitors. [PDF]

Pharmaceuticals (Basel)
Tok F, Sağlık Özkan BN, Özkay Y, Kaplancıklı ZA.   +3 more
europepmc   +1 more source

Letter to the Editor "Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer". [PDF]

Breast
Verma A, Hoysal DR, Deshpande A, Badwe RA.   +3 more
europepmc   +1 more source

Aromatase Inhibitors and Dementia Risk: Putting Safety Into Perspective. [PDF]

Pharmacol Res Perspect
Rizk M, Mokbel K.
europepmc   +1 more source

Evaluation of Ginsenosides and Their Derivatives From <i>Panax ginseng</i> as Aromatase Inhibitors for Breast Cancer Treatment-An <i>in silico</i> study. [PDF]

Biomed Res Int
Madhan JG, Sekaran S, Akshaya RN, Venkatesan K, Kirupanandasamy K, Vijayakumar K, Jenifer N, Paul BC.   +7 more
europepmc   +1 more source